Differentiating cardiac amyloidosis from hypertrophic cardiomyopathy: which deformation imaging parameter is the best? Value of the ejection fraction basal strain ratio

C.P. Piazzai (1) , C.L. Lavoute (1) , N.R. Resseguier (1) , J.H. Haentjens (1) , Anne-Claire Casalta (2, 1) , J.P. Pradier (1) , S.R. Renard (1) , B.S. Simonnet (1) , S.H. Hubert (1) , J.F.A. Avierinos (1) , K.N. Nguyen (1) , Gilbert Habib (3, 1)

1 TIMONE - Hôpital de la Timone [CHU - APHM]
2 Département de Cardiologie [Hôpital de la Timone - APHM]
3 MEPHI - Microbes évolution phylogénie et infections

Domains: Life Sciences [q-bio]; Microbiology and Parasitology; Bacteriology; Life Sciences [q-bio]; Microbiology and Parasitology; Virology; Life Sciences [q-bio]; Microbiology and Parasitology; Parasitology; Life Sciences [q-bio]; Human health and pathology; Cardiology and cardiovascular system; Life Sciences [q-bio]; Human health and pathology; Emerging diseases; Life Sciences [q-bio]; Human health and pathology; Infectious diseases

C.P. Piazzai, C.L. Lavoute, N.R. Resseguier, J.H. Haentjens, Anne-Claire Casalta, et al.. Differentiating cardiac amyloidosis from hypertrophic cardiomyopathy: which deformation imaging parameter is the best? Value of the ejection fraction basal strain ratio. European-Society-of-Cardiology Congress, Aug 2018, Munich, Germany. ⟨hal-02443962⟩